Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: LarryS who wrote (12200)	11/12/1999 9:50:00 AM
From: aknahow	Read Replies (1) \| Respond to of 17367

Larry, we did not speak, I received e-mail. I posted 99.9% of it as she sent it. The peer review committee of the FDA meets only after an application for approval has been submitted. I do not even know if under subpart E that such a committee is required. But that does help in trying to figure out when XOMA will meet with the FDA. The data, must be very complex, having taken so long to analyze. We should remember that the trial was stratified by degree of severity. (8-11) and (12-15). In spite of the best R.D. computer, it probably takes more than a few hours to analyze and understand the data. The R.D. is a private joke, related to phony and funny, which do indeed sound alike, if you have a noisy windmill spinning nearby.